CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103. A total of 153 filers reported holding CYMABAY THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.08 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $112,488 | +39.1% | 12,900 | 0.0% | 0.02% | +23.5% |
| Q4 2022 | $80,883 | +79.7% | 12,900 | 0.0% | 0.02% | +70.0% |
| Q3 2022 | $45,000 | +18.4% | 12,900 | 0.0% | 0.01% | +25.0% |
| Q2 2022 | $38,000 | -5.0% | 12,900 | 0.0% | 0.01% | +14.3% |
| Q1 2022 | $40,000 | -9.1% | 12,900 | 0.0% | 0.01% | -12.5% |
| Q4 2021 | $44,000 | -6.4% | 12,900 | 0.0% | 0.01% | -27.3% |
| Q3 2021 | $47,000 | – | 12,900 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|